RESEARCH
Non-Neutropenic Enterocolitis Risk Identified in Adjuvant CAPOX TherapyA study examined the incidence and risk factors of non-neutropenic enterocolitis—a potentially serious side effect—in colorectal cancer patients receiving adjuvant capecitabine and oxaliplatin chemotherapy. (Clinical Colorectal Cancer)